| 000 | 01798 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517130559.0 | ||
| 264 | 0 | _c20170714 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0166466 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDesmonde, Sophie | |
| 245 | 0 | 0 |
_aCosts of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire. _h[electronic resource] |
| 260 |
_bPloS one _c2016 |
||
| 300 |
_ae0166466 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xprevention & control |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCote d'Ivoire |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLopinavir _xtherapeutic use |
| 650 | 0 | 4 | _aLost to Follow-Up |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xeconomics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRitonavir _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aAvit, Divine | |
| 700 | 1 | _aPetit, Junie | |
| 700 | 1 | _aAmorissani Folquet, Madeleine | |
| 700 | 1 | _aEboua, Francois Tanoh | |
| 700 | 1 | _aAmani Bosse, Clarisse | |
| 700 | 1 | _aDainguy, Evelyne | |
| 700 | 1 | _aMea, Véronique | |
| 700 | 1 | _aTimite-Konan, Marguerite | |
| 700 | 1 | _aNgbeché, Sylvie | |
| 700 | 1 | _aCiaranello, Andrea | |
| 700 | 1 | _aLeroy, Valeriane | |
| 773 | 0 |
_tPloS one _gvol. 11 _gno. 12 _gp. e0166466 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0166466 _zAvailable from publisher's website |
| 999 |
_c26682637 _d26682637 |
||